It is with great pleasure that we can now announce the completion of a major $1 M investment project within Key Organics; our new process R&D and scale-up facility is now complete and fully operational. This will enable us to better support our customers and deliver more diverse, scale-up projects up to a 50 L capacity, with scope for further scale as needed. We have also completed our Ecovadis accreditation and are on course to be ISO9001 compliant later this year.
This increased capacity, sustainability and quality investments allows us to meet increasing customer needs for FTE, FFS and Custom Chemistry projects and also provide our proprietary BIONET products at a larger scale. Our BIONET product portfolio now contains over 308,000 Building Blocks/Intermediates, Screening Compounds, Fragments and Biochemicals. Our ability to integrate these two capabilities, and at scale provides an enhanced offering to our global customer base.
We have also launched our new corporate video, showcasing the new investments.
